FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma

  • Marc Remke
  • , Thomas Hielscher
  • , Andrey Korshunov
  • , Paul A. Northcott
  • , Sebastian Bender
  • , Marcel Kool
  • , Frank Westermann
  • , Axel Benner
  • , Huriye Cin
  • , Marina Ryzhova
  • , Dominik Sturm
  • , Hendrik Witt
  • , Daniel Haag
  • , Grischa Toedt
  • , Andrea Wittmann
  • , Anna Schöttler
  • , André O. Von Bueren
  • , Andreas Von Deimling
  • , Stefan Rutkowski
  • , Wolfram Scheurlen
    • Andreas E. Kulozik, Michael D. Taylor, Peter Lichter, Stefan M. Pfister

Research output: Contribution to journal › Article › peer-review

147 Citations (Scopus)

Fingerprint

Dive into the research topics of 'FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Neuroscience

Biochemistry, Genetics and Molecular Biology